Press Release

Shanghai Pharmaceuticals Realized Stable Results In the Third Quarter
Oct 30, 2017 22:54 JST

Shanghai Pharmaceuticals Holding Co., Ltd. ("Shanghai Pharmaceuticals" or the "Company" and, together with its subsidiaries, the "Group"; stock code: 601607.SH; 2607.HK), the integrated pharmaceutical company in the PRC that has leading positions in both pharmaceutical products and service markets, today announced its results for the third quarter of 2017.
More info..

Shanghai Pharmaceuticals Realized Stable and Healthy Growth in Interim Results
Aug 28, 2017 23:05 JST

Shanghai Pharmaceuticals Grew Steady in 2017 Q1
Apr 28, 2017 08:11 JST

Shanghai Pharmaceuticals Holding Co., Ltd. ("Shanghai Pharmaceuticals" or the "Company" and, together with its subsidiaries, the "Group"; stock code: 601607.SH; 2607.HK), the integrated pharmaceutical company in the PRC that has leading positions in both pharmaceutical products and service markets, released its first quarterly report of 2017 on the night of 27 April, 2017.
More info..

Shanghai Pharmaceuticals Releases 2016 Annual Results Mar 21, 2017 23:50 JST Shanghai Pharmaceuticals Holding Co., Ltd. (601607.SH; 2607.HK), the integrated pharmaceutical company in the PRC that has leading positions in both pharmaceutical products and service markets, released its 2016 annual results report today. More info..

Shanghai Pharmaceuticals Released 2016 Q3 Results Oct 27, 2016 22:20 JST Shanghai Pharmaceuticals Holding Co., Ltd. today released its third quarterly report of 2016. More info..

Shanghai Pharmaceuticals Released 2016 Interim Results
Aug 25, 2016 23:20 JST

Shanghai Pharmaceuticals Holding Co., Ltd. ("Shanghai Pharmaceuticals" or the "Company" and, together with its subsidiaries, the "Group"; stock code: 601607.SH; 2607.HK), the integrated pharmaceutical company in the PRC that has leading positions in both pharmaceutical products and service markets, today released its interim results for the first half of 2016 (the "reporting period").
More info..

Shanghai Pharmaceuticals Released 2016 Q1 Results
Apr 29, 2016 08:21 JST

Shanghai Pharmaceuticals Holding Co., Ltd. ("Shanghai Pharmaceuticals" or the "Company" and, together with its subsidiaries, the "Group"; stock code: 601607.SH; 2607.HK), the integrated pharmaceutical company in the PRC that has leading positions in both pharmaceutical product and service markets, today released its first quarterly report of 2016
More info..

Shanghai Pharmaceuticals Released 2015 Annual Results: Operating Revenue Reached a New High of over 100 Billion for the First Time
Mar 19, 2016 08:46 JST

Shanghai Pharmaceuticals Holding Co., Ltd. ("Shanghai Pharmaceuticals" or the "Company" and, together with its subsidiaries, the "Group"; stock code: 601607.SH; 2607.HK), the integrated pharmaceutical company in the PRC that has leading positions in both pharmaceutical product and distribution markets, today released its annual report of 2015.
More info..

Shanghai Pharmaceuticals Released 2015Q3 Results Oct 29, 2015 22:00 JST Shanghai Pharmaceuticals Holding Co., Ltd. ("Shanghai Pharmaceuticals" or the "Company" and, together with its subsidiaries, the "Group"; stock code: 601607.SH; 2607.HK) More info..

Shanghai Pharmaceuticals Achieves Steady Growth of Revenue and Profit for 1H2015
Aug 26, 2015 23:45 JST

Shanghai Pharmaceuticals Holding Co., Ltd. ("Shanghai Pharmaceuticals" or the "Company" and, together with its subsidiaries, the "Group"; stock code: 601607.SH; 2607.HK), the pharmaceutical group in the PRC that has leading positions in both pharmaceutical product and distribution markets, today announced its interim results for the first half of 2015.

More info..

Shanghai Pharmaceuticals and Jingdong Announced Comprehensive Strategic Cooperation in Strategies, Capital and Businesses
May 18, 2015 19:55 JST

Shanghai Pharmaceuticals Holding Co. Ltd., ("Shanghai Pharmaceuticals" or the "Company" and, together with its subsidiaries, the "Group"; stock code: 601607.SH; 02607.HK), announced on 17 May that the Company has entered into a strategic cooperative framework agreement with Beijing Jingdong Century Trading Co., Ltd. ("Jingdong").
More info..

Shanghai Pharmaceuticals Shows Strong Momentum in Q1 Revenue and Net Profit Apr 28, 2015 22:20 JST Shanghai Pharmaceuticals Holding Co. Ltd., ("Shanghai Pharmaceuticals" or the "Company" and, together with its subsidiaries, the "Group"; stock code: 601607.SH; 02607.HK) More info..

Shanghai Pharmaceuticals Maintains a Steady Growth for Business Performance; Makes a Clear Path for Future Development
Mar 26, 2015 23:00 JST

Shanghai Pharmaceuticals Holding Co. Ltd., ("Shanghai Pharmaceuticals" or the "Company" and, together with its subsidiaries, the "Group"; stock code: 601607.SH; 02607.HK), today announced its annual results for the year ended 31 December 2015 (the "reporting period").

More info..

Shanghai Pharmaceuticals Invests to Set Up E-commerce Company; "Three Platforms, Three Layers of Networks" Mar 10, 2015 20:36 JST The integrated pharmaceutical company in the PRC that has leading positions in both pharmaceutical products and distribution markets - Shanghai Pharmaceuticals Holding Co., Ltd. More info..

Shanghai Pharmaceuticals Achieves Double-Digit Growth of Revenue and Profit for 1H2014
Aug 27, 2014 22:51 JST

Shanghai Pharmaceuticals Holding Co., Ltd. ("Shanghai Pharmaceuticals" or the "Company" and, together with its subsidiaries, the "Group; stock code: 601607.SH; 2607.HK), the integrated pharmaceutical company in the PRC that has leading positions in both pharmaceutical product and distribution markets
More info..

Shanghai Pharmaceuticals 2013 Annual Results Mar 31, 2014 16:25 JST Shanghai Pharmaceuticals Holding Co. Ltd. recorded operating revenue of RMB78.223 billion, up by 14.90% on a YOY basis. Net profit attributable to the equity holders of the listed Company was RMB2.243 billion, up by 9.26% on a YOY basis, and reached a growth of 15.16% after deducting non-recurring profit or loss. More info..

Pfizer and Shanghai Pharmaceutical Sign Memorandum of Understanding for Potential Strategic Partnership Apr 20, 2011 23:50 JST Shanghai Pharmaceutical Co. Ltd. (SHSE: 601607) and Pfizer Inc. (NYSE: PFE) today announced the signing of a memorandum of understanding (MOU) for the companies to jointly pursue potential business opportunities in China. More info..